HOCP.Y Stock Overview
A med-tech company, provides high-tech and medical products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HOCP.Y from our risk checks.
HOYA Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥118.11 |
| 52 Week High | JP¥135.00 |
| 52 Week Low | JP¥95.04 |
| Beta | 0.66 |
| 11 Month Change | -0.50% |
| 3 Month Change | -5.60% |
| 1 Year Change | 1.82% |
| 33 Year Change | -13.55% |
| 5 Year Change | 55.55% |
| Change since IPO | 370.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| HOCP.Y | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.2% | -0.4% | -0.3% |
| 1Y | 1.8% | -0.9% | 22.3% |
Return vs Industry: HOCP.Y exceeded the US Medical Equipment industry which returned -1% over the past year.
Return vs Market: HOCP.Y underperformed the US Market which returned 24.2% over the past year.
Price Volatility
| HOCP.Y volatility | |
|---|---|
| HOCP.Y Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: HOCP.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: HOCP.Y's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 35,702 | Eiichiro Ikeda | www.hoya.com |
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
HOYA Corporation Fundamentals Summary
| HOCP.Y fundamental statistics | |
|---|---|
| Market cap | US$41.23b |
| Earnings (TTM) | US$1.14b |
| Revenue (TTM) | US$4.78b |
36.3x
P/E Ratio8.6x
P/S RatioIs HOCP.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HOCP.Y income statement (TTM) | |
|---|---|
| Revenue | JP¥762.61b |
| Cost of Revenue | JP¥340.92b |
| Gross Profit | JP¥421.69b |
| Other Expenses | JP¥240.32b |
| Earnings | JP¥181.38b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 01, 2024
| Earnings per share (EPS) | 518.24 |
| Gross Margin | 55.30% |
| Net Profit Margin | 23.78% |
| Debt/Equity Ratio | 0.3% |
How did HOCP.Y perform over the long term?
See historical performance and comparison